Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?

Varanauskienė, Eglė

doi:10.1016/j.diabres.2008.09.025

Cited by 7 publications

(4 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiovascular risk factors in T2D have been shown to be directly related to PPG levels. 25 The beneficial cardiovascular effects of diabetes therapy may relate to the type of therapeutic agent used, with GLP-1 RAs, in particular, having a PPG-lowering effect. 26 GLP-1 RAs, as well as sodium glucose cotransporter 2 inhibitors, have demonstrated significant improvements in GV.…”

Section: Effects Of Gv On Patientsmentioning

confidence: 99%

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes

Umpiérrez

Kovatchev

2018

The American Journal of the Medical Sciences

104

View full text Add to dashboard Cite

Glycated hemoglobin A1c (A1C) levels have traditionally been the gold standard for assessing glycemic control and treatment efficacy in patients with type 2 diabetes. However, A1C does not take into account fluctuations in blood glucose levels known as glycemic variability (GV). In recent years, GV has become increasingly clinically relevant, because of a better understanding of the need to reach target A1C while avoiding hypoglycemia. GV relates to both hyperglycemia and hypoglycemia, and has been associated with poorer quality of life. Diabetes treatments targeting multiple pathophysiological mechanisms are most beneficial in controlling A1C and reducing GV. In clinical trials, a number of metrics are used to measure GV, many of which are not well understood in the clinical practice. Until a gold standard metric for GV is established, the variety of measurements available may confound the choice of an optimal treatment for an individual patient.

show abstract

Section: Effects Of Gv On Patientsmentioning

confidence: 99%

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes

Umpiérrez

Kovatchev

2018

The American Journal of the Medical Sciences

104

View full text Add to dashboard Cite

show abstract

“…Current diabetes care depends on measurements of HbA1c levels and self-monitored blood glucose (SMBG) levels to assess the quality of glycemic control and to adjust management. SMBG has been shown to be effective for improving glycemic control in patients with insulin treated type 2 diabetes mellitus [ 4 ]. However, the usefulness of SMBG in the management of patients with non-insulin treated type 2 diabetes mellitus is not convincing [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of 3-Day Continuous Glucose Monitoring for Improving Glucose Control in Type 2 Diabetic Patients in Clinical Practice

Kim

Hur

et al. 2014

Diabetes Metab J

View full text Add to dashboard Cite

BackgroundThe aim of this study was to investigate whether adjusting diabetic treatment regimens according to the information obtained from a continuous glucose monitoring system (CGMS) might lead to improved glycemic control in patients with type 2 diabetes.MethodsWe reviewed the medical charts of 172 patients who used the CGMS for 1 year starting in December 2008 and the records of 1,500 patients who visited their regular outpatient clinics during December 2008. Of these patients, a total of 65 CGMS patients and 301 regular outpatients (control group) were enrolled in the study after propensity score matching. There were no differences in baseline glycated hemoglobin (HbA1c), age, and duration of diabetes between the CGMS and the control groups after propensity score matching. The changes in the HbA1c levels from baseline to 6 months were calculated.ResultsThe CGMS group showed a significant improvement in the HbA1c level compared to the control group at 3 months (7.9%±1.6% vs. 7.4%±1.2%, P=0.001) and at 6 months (7.4%±1.2% vs. 7.9%±1.6%, P=0.010). There were significant differences in the treatment modality changes between the CGMS group and the control group.ConclusionUsing a 3-day CGMS was advantageous for improving glucose control in patients with type 2 diabetes and may help these patients to optimize glycemic control in clinical practice.

show abstract

“…We analyzed the characteristics of four participants in the IG and two in the CG who failed to reach stage 4 for dietary-therapy-related self-management behaviors (action stage; see Table 1), which indicated that the nurses failed to motivate them in this regard. Their common characteristics were: 1) they were at stage 3 (preparation) or lower for exercise and self-monitoring at the end of the program period; and 2) they were obese (BMI range: [26][27][28][29][30][31][32][33][34][35][36][37][38][39][40]. By the end of the program, five of these six participants had not developed self-monitoring habits, and only two of the participants from the IG, and none from the CG, achieved the weight-loss targets.…”

Section: Qualitative Analysis Of Participants Who Did Not Show Behavimentioning

confidence: 99%

“…Obtaining accurate information needed for health assessments: As mentioned above, the nurses felt that it was difficult to motivate patients based on detailed physical risk assessment. For patients with diabetes, improving self-monitoring ability and the motivation to perform selfmonitoring and to adhere to treatment are essential components for the adoption of self-management behaviors that improve the health condition and QOL [31][32][33]. In order to achieve this goal through the medium of telenursing, improvement in telecommunication is necessary, as this would allow nurses to assess patients' physical conditions, and would also allow the patients to gain an understanding of their physical status and the effects of self-management [34].…”

Section: Feasibilitymentioning

confidence: 99%

Evaluating the effectiveness and feasibility of nurse-led distant and face-to-face interviews programs for promoting behavioral change and disease management in patients with diabetic nephropathy: a triangulation approach

et al. 2020

View full text Add to dashboard Cite

Background: We examined whether telecommunication-device-based distance interviews are inferior to face-toface interviews in terms of facilitating behavioral changes and disease management in patients with diabetic nephropathy. We also examined the feasibility of a newly designed six-month telenursing program. Methods: This study represents a post-hoc analysis of data from a randomized controlled trial, in which we compared the efficacy of remote self-management education with that of direct education for patients with diabetic nephropathy. The participants were 40 company employees, who were randomly divided into two groups. Over 6 months, the intervention group (n = 21) received three distance interviews using a tablet computer. Meanwhile, the control group (n = 19) received three face-to-face interviews. In addition, both groups received biweekly nine telephone calls. A triangulation approach was used. We first compared the two groups in inferiority tests. Then, we analyzed data from semi-structured interviews with all participants and nurses, examining whether trusting relationships and motivation were developed, and the accuracy of the information exchanges. Further, for the intervention group, we also enquired about the overall operability of the telenursing device. Results: The completion rates for the program were 81.0 and 78.9% for the participants in the intervention and control groups, respectively. Both groups showed similar behavioral changes, and the participants verified the feasibility of the distance interviews. The participants in the intervention group felt that they understood the severity of their diseases and the necessity of self-management, and felt confidence in the nurses. On the other hand, their degree of behavioral change regarding self-monitoring was lower than that shown by the control group.

show abstract

Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?

Cited by 7 publications

References 62 publications

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes

Effectiveness of 3-Day Continuous Glucose Monitoring for Improving Glucose Control in Type 2 Diabetic Patients in Clinical Practice

Evaluating the effectiveness and feasibility of nurse-led distant and face-to-face interviews programs for promoting behavioral change and disease management in patients with diabetic nephropathy: a triangulation approach

Contact Info

Product

Resources

About